All4NutraNo products in the cart.
All4NutraInnovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA’s Center ...
had slowed down the speed at which generic active pharmaceutical ingredient (API) manufacturers were submitting Drug Master Files (DMFs) to ...
The FDA understands that there is increasing interest in the potential utility of cannabis for a variety of medical conditions, ...
Florham Park, New Jersey, December 5, 2022 – BASF Pharma Solutions, a global business unit of BASF, announces today that ...
Register now and save $200. (Early Bird) Until March 10, Early Bird Price: $1,295.00 From March 11 to April 24, ...
Abstract The Knowledge-Aided Assessment and Structured Application (KASA) is an initiative led by the FDA’s Center for Drug Evaluation and ...
lower new drug approvals in mid-2020. But our mid-2020 recap published in July, which looked at new drug approvals by ...
A. FDA Issues notice on “Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities (NDSRIs) and requests comments”. While the ...
Food and Drug Administration convened a high-level internal working group to explore potential regulatory pathways for CBD products. Today we ...
04. January 2018 The year gone by saw the highest number of generic drug approvals by the US Food ...
Copyright: PharmaExcipients AG